Journals Higher Education
Important OUP's Response to COVID-19 Learn more



This item is printed to order. Items which are printed to order are normally despatched and charged within 5-10 days.

Published: 18 January 2018

472 Pages


ISBN: 9780198803539

Also Available As:


Bookseller Code (AJ)

A new practitioner law publication

Drug and Device Product Liability Litigation Strategy

Second Edition

Mark Herrmann, David B Alden, and Geoffrey Drake

  • Comprehensive discussion of all aspects of drug and device product liability litigation, from pre-litigation risk assessments through trial
  • Offers thoughtful, expert advice and discussions from experienced drug and device litigators on navigating the host of challenges presented by this rapidly evolving field
  • Updated to include analysis and thorough discussion of key shifts in the legal landscape since the publication of the first edition

New to this Edition:

  • Thorough and extensive revisions to reflect recent legal developments, including key court decisions and statutes
  • Comprehensive discussion of the federal drug preemption landscape following the Supreme Court's Wyeth, Mensing, and Bartlett Trilogy
  • Analysis of recent trends in federal multidistrict litigation
  • Updated collection of key decisions and statutory developments regarding the learned intermediary doctrine, innovator liability, and the admissibility of expert testimony
  • New discussion regarding pre-litigation counselling and the amended Federal Rules of Civil Procedure governing discovery
  • Expanded discussion of the grounds for excluding key evidence before trial through motions in limine
  • Discussion of recent Supreme Court decisions on personal jurisdiction and the impact on plaintiffs' ability to aggregate cases in various state jurisdictions

Also of Interest

Related Categories

Law > Medical & Healthcare Law
Law > Tort Law